Test Background Levetiracetam (brand name Keppra) is approved for adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy. It is also efficacious in children with partial seizures and there are indications that it may be effective in generalised seizures.
Clinical Indications Assessment of patient compliance Assessment of suspected toxicity
Reference Range See report
Sample Required SST (gold top), serum (red top) or heparin (green top)
Sample Volume 1 mL pre-dose trough sample
Turnaround Time Up to 6 weeks
Notes Not currently performed in house; this is a referred test.